The question then arises: What is the factor that overcomes BCR–ABL1 and suppresses Akt activation in CML stem cells such that Foxo3a is allowed to function? This evidence concerns the gene FOXO3 and chronic myelogenous leukemia, BCR-ABL1 positive.